Literature DB >> 21220769

Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.

Elisabetta Mantengoli, Francesco Luzzaro, Patrizia Pecile, Daniela Cecconi, Annalisa Cavallo, Letizia Attala, Alessandro Bartoloni, Gian Maria Rossolini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21220769     DOI： 10.1093/cid/ciq194

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  12 in total

1.  Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae.

Authors:  Dearbháile Morris; Edel McGarry; Meaghan Cotter; Virginie Passet; Maureen Lynch; Catherine Ludden; Margaret M Hannan; Sylvain Brisse; Martin Cormican
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

2.  Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone.

Authors:  Dearbháile Morris; Fiona Boyle; Catherine Ludden; Iris Condon; James Hale; Nuala O'Connell; Lorraine Power; Teck Wee Boo; Hiran Dhanji; Christian Lavallee; Neil Woodford; Martin Cormican
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

Review 3.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 4.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.

Authors:  Sheila Adams-Sapper; Binh An Diep; Francoise Perdreau-Remington; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

6.  Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Krystyna M Kazmierczak; Sharon Rabine; Meredith Hackel; Robert E McLaughlin; Douglas J Biedenbach; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

7.  Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.

Authors:  Kayoko Hayakawa; Tohru Miyoshi-Akiyama; Teruo Kirikae; Maki Nagamatsu; Kayo Shimada; Kazuhisa Mezaki; Yuko Sugiki; Emi Kuroda; Shiho Kubota; Nozomi Takeshita; Satoshi Kutsuna; Masayoshi Tojo; Norio Ohmagari
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

8.  Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance.

Authors:  Johann D D Pitout
Journal:  Front Microbiol       Date:  2012-01-19       Impact factor: 5.640

9.  Verona integron-encoded metallo-β-lactamase 1 in Enterobacteria, Ontario, Canada.

Authors:  Nathalie Tijet; Gregory Macmullin; Olga Lastovetska; Christie Vermeiren; Patricia Wenzel; Tina Stacey-Works; Donald E Low; Samir N Patel; Roberto G Melano
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

10.  The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in Kuwait.

Authors:  Ali A Dashti; Leila Vali; Sherief El-Shazly; Mehrez M Jadaon
Journal:  BMC Microbiol       Date:  2014-08-28       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.